Bayer Introduces New Birth Control Device Amidst Mounting Mirena IUD Lawsuits
As Mirena IUD lawsuits mount, drugmaker Bayer Healthcare Pharmaceuticals is gearing up to introduce a new intrauterine birth control device. Skyla, an IUD otherwise known as a levonorgestrel-releasing intrauterine system, was recently approved by the U.S. Food and Drug Administration (FDA) to prevent pregnancy for up to three years. This is the first IUD birth control device introduced by Bayer in 12 years.
Skyla will be aimed at younger women who have not yet had any children, unlike its predecessor, Mirena, which is encouraged for use in women who have already had at least one child.
News of this recently unveiled birth control device comes amidst talks of creating a consolidated litigation for federally-filed Mirena IUD lawsuits.
Plaintiffs in these cases allege the following Mirena side effects: abscesses, infection, uterine perforations, embedment in the uterine wall, intestinal perforations or obstruction, pelvic inflammatory disease and ectopic pregnancy.
Many of these Mirena side effects can potentially harm a young woman's fertility since they often require revision surgeries to correct.
In the press release issued for the release of its new birth control IUD, Bayer Pharmaceuticals released the following statement: "Skyla is more than 99 percent effective at preventing pregnancy and may be appropriate for women who want a birth control method that they do not have to take daily. Further, Skyla may be used by women whether or not they have ever had a child, representing an important new choice for women who don't want to become pregnant for up to three years."
In January, plaintiffs in Mirena IUD lawsuits filed a motion to streamline pre-trial proceedings of pending and future claims filed over the device by creating a multidistrict litigation (MDL) in the U.S. District Court for the Northern District of Ohio. If the request, filed Jan. 16, 2013 with the U.S. Judicial Panel on Multidistrict Litigation is granted, all pending and future cases will be transferred to that location, where they will be overseen by a single judge. According to the petition, eight Mirena IUD lawsuits are currently pending in federal court.
Mirena lawsuits allege the IUD can spontaneously migrate within a woman's body, causing a host of severe complications. If the Mirena IUD migrates from its original placement in the uterus, it no longer works to prevent pregnancy. If she does become pregnant, the woman may experience an ectopic pregnancy.
Thus, the device was designed defectively by Bayer Healthcare Pharmaceuticals Inc.
Skyla will be aimed at younger women who have not yet had any children, unlike its predecessor, Mirena, which is encouraged for use in women who have already had at least one child.
News of this recently unveiled birth control device comes amidst talks of creating a consolidated litigation for federally-filed Mirena IUD lawsuits.
Plaintiffs in these cases allege the following Mirena side effects: abscesses, infection, uterine perforations, embedment in the uterine wall, intestinal perforations or obstruction, pelvic inflammatory disease and ectopic pregnancy.
Many of these Mirena side effects can potentially harm a young woman's fertility since they often require revision surgeries to correct.
In the press release issued for the release of its new birth control IUD, Bayer Pharmaceuticals released the following statement: "Skyla is more than 99 percent effective at preventing pregnancy and may be appropriate for women who want a birth control method that they do not have to take daily. Further, Skyla may be used by women whether or not they have ever had a child, representing an important new choice for women who don't want to become pregnant for up to three years."
In January, plaintiffs in Mirena IUD lawsuits filed a motion to streamline pre-trial proceedings of pending and future claims filed over the device by creating a multidistrict litigation (MDL) in the U.S. District Court for the Northern District of Ohio. If the request, filed Jan. 16, 2013 with the U.S. Judicial Panel on Multidistrict Litigation is granted, all pending and future cases will be transferred to that location, where they will be overseen by a single judge. According to the petition, eight Mirena IUD lawsuits are currently pending in federal court.
Mirena lawsuits allege the IUD can spontaneously migrate within a woman's body, causing a host of severe complications. If the Mirena IUD migrates from its original placement in the uterus, it no longer works to prevent pregnancy. If she does become pregnant, the woman may experience an ectopic pregnancy.
Thus, the device was designed defectively by Bayer Healthcare Pharmaceuticals Inc.
Source...